A Phase I, Open-Label, Multi-Center Dose-Finding and Expansion Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of CR-001 (5-Fu-mir-15a) in Patients with Acute Myeloid Leukemia
medrxiv(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要